Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Altastaph in Low-Birth-Weight Neonates
NCT00066989Phase 2Completed
- Sponsor
- Nabi Biopharmaceuticals
- Start
- Jul 2003
- Primary completion
- Aug 2004
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
01
Overview
A Phase 2 trial of altastaph in staphylococcal infection, sponsored by Nabi Biopharmaceuticals. Started Jul 2003; status: completed.
02
Drugs
altastaph
03
Conditions
staphylococcal infection
Beyond the preview
Go deeper on NCT00066989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066989.